Hebron Technology Co., Ltd. Exhibited at ACHEMA
WENZHOU, China, June 18, 2018 /PRNewswire/ — Hebron Technology Co., Ltd. (“Hebron” or the “Company”) (Nasdaq: HEBT), a developer, manufacturer and installer of valves and pipe fittings for use in…
The Art & Science of Wellness
WENZHOU, China, June 18, 2018 /PRNewswire/ — Hebron Technology Co., Ltd. (“Hebron” or the “Company”) (Nasdaq: HEBT), a developer, manufacturer and installer of valves and pipe fittings for use in…
The company has leveraged its expertise in Artificial Intelligence, Big Data analytics, and blockchain to create an ecosystem of cutting-edge solutions to support R&D for aging-related products and solutions LONDON,…
WENZHOU, China, June 12, 2018 /PRNewswire/ — Hebron Technology Co., Ltd. (“Hebron” or the “Company”) (Nasdaq: HEBT), a developer, manufacturer and installer of valves and pipe fittings for use in…
SINGAPORE, June 18, 2018 /PRNewswire/ — FrieslandCampina today announces the publication of a milk consumption trends study in SciFed Food and Dairy Technology Journal. This study is the first of…
NEW YORK, June 12, 2018 /PRNewswire/ — HelpMeSee is presenting their Eye Surgery Simulator and companion eBook for teaching Manual Small Incision Cataract Surgery (MSICS) at the International Council of…
TAIPEI, Taiwan and SAN DIEGO, June 12, 2018 /PRNewswire/ — Senhwa Biosciences Inc. (6492.TT) announced that the company and the Pediatric Brain Tumor Consortium (PBTC, US, www.pbtc.org) have signed a…
MILAN, June 16, 2018 /PRNewswire/ — SOPHiA GENETICS, global leader in Data-Driven Medicine, announced today at the European Human Genetics Conference (ESHG 2018) that it has completed the acquisition of…
VISULAS® green, the next generation of photocoagulation laser from ZEISS allows doctors to fully concentrate on the patient’s treatment procedure without interruption. BARCELONA, Spain, June 16, 2018 /PRNewswire/ — Today,…
SHANGHAI, June 12, 2018 /PRNewswire/ — Shanghai ChemPartner today announced the appointment of Ming Liu, Ph.D. as Vice President and the Head of Biology and Pharmacology at the company headquarters…
SUZHOU, China, June 13, 2018 /PRNewswire/ — CStone Pharmaceuticals (“CStone”) today announced that two pivotal Phase II studies exploring the efficacy and safety of CS1001 in patients with natural killer…
Multilingual WordPress with WPML